Results for Lifespan Research

Dr. Anderson’s research interests focus on the molecular and cellular mechanisms that govern the development of the mammalian forebrain. In his research on the development of the cerebral cortex, he is particularly interested in understanding the molecular underpinnings behind the fate determination and axon targeting of subclasses of GABAergic interneurons implicated in the neuropathology of schizophrenia.

Dr. Gur's combined training in Psychology, Neurology, and Psychiatry enabled her to pursue an academic career working with basic and clinical neuroscientists to advance the understanding mental disorders.

Dr. Forrest's research focuses on developing novel ways of conducting multi-center pediatric applied clinical research, child health services and outcomes research, pediatric person-reported outcome measure development and application, life course health science, learning health systems science, and policies and programs that promote the lifelong health of children. He has a particular interest in the concept and measurement of health.

Dr. Miller's research focuses on diagnostic and outcome issues, including differentiating autism from other genetic and psychiatric conditions, diagnostic and outcome studies across the lifespan, early identification and screening, and improving systems of care.

Research by Dr. Yerys focuses on the development of cognitive and neural mechanisms that support adaptive behavior in children with neurodevelopmental disorders.

Dr. Gottardi leads the Bioengineering and Biomaterials (Bio²) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders. Dr. Gottardi researches mechanisms of laryngotracheal pathologies, applies tissue engineering to improve pediatric conditions, develops new devices, and formulates controlled drug delivery systems to treat and improve patients’ lives.

Dr. Parish-Morris investigates social communication, specifically how vocal communication develops in children and adolescents with autism spectrum disorder. She uses computational approaches and machine learning to identify objective and reliable behavioral markers for use in screening, treatment and intervention response tracking, and to advance biological research.

Dr. Mukhopadhyay’s research interests include neonatal infectious disease epidemiology, the developing microbiome and the effect of these early-life factors on later childhood health outcomes.

Dr. Benton's research focuses primarily on pediatric mood and anxiety disorders, sickle cell disease and psychiatric conditions, HIV and psychiatric conditions, neuroimmunology and mood disorders, health services research, eating disorders, and ethnically diverse children.

Dr. Shults works to develop statistical methods for longitudinal data that include semi-parametric approaches to account for subject/cluster level associations and maximum likelihood-based approaches for simulation and analysis of discrete longitudinal outcomes that may have overdispersion.